BINEX Co. Ltd (053030) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.019x

Based on the latest financial reports, BINEX Co. Ltd (053030) has a cash flow conversion efficiency ratio of 0.019x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩3.62 Billion ≈ $2.45 Million USD) by net assets (₩187.21 Billion ≈ $126.87 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Check 053030 capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.

BINEX Co. Ltd - Cash Flow Conversion Efficiency Trend (2005–2024)

This chart illustrates how BINEX Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. See BINEX Co. Ltd shareholders equity for net asset value and shareholders' equity analysis.

BINEX Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of BINEX Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
J.Jill Inc NYSE:JILL	-0.013x
AMIA Co. Ltd. TW:8438	0.062x
Oriental Interest Bhd KLSE:5827	0.004x
Embecta Corp NASDAQ:EMBC	-0.050x
Sarfati TA:SRFT	-0.071x
Medinice S.A WAR:ICE	-0.020x
Green Landscaping Group AB (publ) ST:GREEN	0.078x
United Bankers Oyj HE:UNITED	0.022x

Annual Cash Flow Conversion Efficiency for BINEX Co. Ltd (2005–2024)

The table below shows the annual cash flow conversion efficiency of BINEX Co. Ltd from 2005 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of BINEX Co. Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩181.61 Billion ≈ $123.07 Million	₩-9.43 Billion ≈ $-6.39 Million	-0.052x	-349.11%
2023-12-31	₩181.33 Billion ≈ $122.88 Million	₩3.78 Billion ≈ $2.56 Million	0.021x	-76.60%
2022-12-31	₩191.61 Billion ≈ $129.85 Million	₩17.06 Billion ≈ $11.56 Million	0.089x	-42.77%
2021-12-31	₩180.42 Billion ≈ $122.27 Million	₩28.07 Billion ≈ $19.02 Million	0.156x	+35.30%
2020-12-31	₩173.22 Billion ≈ $117.39 Million	₩19.92 Billion ≈ $13.50 Million	0.115x	+71.13%
2019-12-31	₩160.50 Billion ≈ $108.77 Million	₩10.78 Billion ≈ $7.31 Million	0.067x	-25.95%
2018-12-31	₩149.43 Billion ≈ $101.27 Million	₩13.56 Billion ≈ $9.19 Million	0.091x	+43.61%
2017-12-31	₩128.75 Billion ≈ $87.25 Million	₩8.14 Billion ≈ $5.51 Million	0.063x	+133.80%
2016-12-31	₩140.55 Billion ≈ $95.25 Million	₩3.80 Billion ≈ $2.57 Million	0.027x	+186.63%
2015-12-31	₩144.14 Billion ≈ $97.68 Million	₩-4.50 Billion ≈ $-3.05 Million	-0.031x	-64.56%
2013-12-31	₩97.45 Billion ≈ $66.04 Million	₩-1.85 Billion ≈ $-1.25 Million	-0.019x	-206.41%
2011-12-31	₩70.58 Billion ≈ $47.83 Million	₩1.26 Billion ≈ $852.26K	0.018x	-80.30%
2007-12-31	₩34.50 Billion ≈ $23.38 Million	₩3.12 Billion ≈ $2.11 Million	0.090x	+14.74%
2006-12-31	₩31.91 Billion ≈ $21.62 Million	₩2.52 Billion ≈ $1.70 Million	0.079x	+54.89%
2005-12-31	₩28.99 Billion ≈ $19.64 Million	₩1.48 Billion ≈ $999.86K	0.051x	--

About BINEX Co. Ltd

KQ:053030 Korea Pharmaceuticals

Market Cap

$194.87 Million

₩287.55 Billion KRW

Market Cap Rank

#16746 Global

#675 in Korea

Share Price

₩9220.00

Change (1 day)

-5.34%

52-Week Range

₩8920.00 - ₩18490.00

All Time High

₩36100.00